Ticker > Company >

Anondita Medicare share price

Anondita Medicare Ltd.

  8.44 K   4   2 NSE: ANONDITA SECTOR: Household & Personal Products

999.40
-24.35 (-2.38%)
NSE: Today, 03:56 PM

Price Summary

Today's High

₹ 1035

Today's Low

₹ 995.1

52 Week High

₹ 1309.58

52 Week Low

₹ 435.96

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 1903.34 Cr.

Enterprise Value

₹ 1927.07 Cr.

No. of Shares

1.9 Cr.

P/E

70.97

P/B

9.33

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  107.14

CASH

₹ 9.54 Cr.

DEBT

₹ 33.27 Cr.

Promoter Holding

59.26 %

EPS (TTM)

₹  14.08

Sales Growth

84.58%

ROE

38.14 %

ROCE

39.75%

Profit Growth

145.83 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Index Presence

The company is present in 1Indices.

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year84.58%
3 YearNA
5 YearNA

Profit Growth

1 Year145.83%
3 YearNA
5 YearNA

ROE%

1 Year38.14%
3 Year37.62%

ROCE %

1 Year39.75%
3 Year33.1%

Debt/Equity

0.2944

Price to Cash Flow

502.38

Interest Cover Ratio

11.4404

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2026 59.26 0.00
Mar 2026 62.40 0.00
Sep 2025 61.79 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROE of 37.6217666666667% over the past 3 years.
  • Company has been maintaining healthy ROCE of 33.0957% over the past 3 years.
  • Company has a healthy Interest coverage ratio of 11.4404.
  • Company’s PEG ratio is 0.879575237350657.
  • The company has an efficient Cash Conversion Cycle of 82.9932 days.
  • Company has a healthy liquidity position with current ratio of 3.1677.
  • The company has a high promoter holding of 59.26%.

 Limitations

  • The company has shown a poor profit growth of 0% for the Past 3 years.
  • The company has shown a poor revenue growth of 0% for the Past 3 years.
  • The company has a low EBITDA margin of 0% over the past 5 years.
  • The company is trading at a high PE of 70.97.
  • The company is trading at a high EV/EBITDA of 48.0364.

Quarterly Result (All Figures in Cr.)

 Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2024 Mar 2025 Mar 2026
Net Sales 0 60.52 111.7
Total Expenditure 0 42.61 72.37
Operating Profit 0 17.9 39.32
Other Income 0 0.36 1.76
Interest 0 2.91 3.5
Depreciation 0 0.75 1.07
Exceptional Items 0 0 0
Profit Before Tax 0 14.61 36.51
Tax 0 3.7 9.69
Net Profit 0 10.91 26.82
Adjusted EPS (Rs.) -0.25 8.21 14.83

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2024 Mar 2025 Mar 2026
Equity and Liabilities
Share Capital 0.1 13.29 18.09
Total Reserves 0 14.3 94.94
Borrowings 0 11.91 23.6
Other N/C liabilities 0 0.18 2.11
Current liabilities 0.01 23.56 24.19
Total Liabilities 0.1 63.25 162.93
Assets
Net Block 0 12.35 39.08
Capital WIP 0 6.5 41.5
Intangible WIP 0 0 0
Investments 0 3.52 3.52
Loans & Advances 0 0.38 2.21
Other N/C Assets 0 0 0
Current Assets 0.1 40.5 76.63
Total Assets 0.1 63.25 162.93
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2024 Mar 2025 Mar 2026
Profit from operations 0 14.61 36.51
Adjustment 0 3.6 4.45
Changes in Assets & Liabilities -0.07 2.07 -33.96
Tax Paid 0 -0.42 -3.22
Operating Cash Flow -0.07 19.86 3.79
Investing Cash Flow 0 -25.59 -61.42
Financing Cash Flow 0.1 6.06 66.82
Net Cash Flow 0.03 0.33 9.19

Corporate Actions

Investors Details

PARTICULARS Sep 2025% Mar 2026% Sep 2026%
promoters 61.79 62.40 59.26
anupam ghosh 61.71 61.99 58.87
reshant ghosh 0.09 0.25 0.24
sonia ghosh - 0.17 0.16
PARTICULARS Sep 2025% Mar 2026% Sep 2026%
investors 38.21 37.60 40.74
mansi share & stock broki... - 1.63 1.73
mohit vinodkumr agrawal - - 1.53
ritu bapna - - 1.90
sagar brahmbhatt - - 1.14
sageone-flagship growth o... 3.01 - 5.37
siddharth iyer - 1.28 1.94
vanaja sunder iyer - - 3.29
vikasa india eif i fund -... - 2.12 1.14
llp - 0.86 -
moheet vinodkumar agarwal... - 3.05 -
ritu bapna 1.91 1.91 -
sagar p brahmbhatt 1.31 1.24 -
sageone - flagship growth... - 1.75 -
sageone - flagship growth... - 2.92 -
vanaja sundar iyer - 1.59 -
cognizant capital dynamic... 1.92 - -
moheet vinodkumar agrawal... 3.05 - -
si investments and brokin... 1.87 - -
vikasa india eif i fund -... 2.12 - -

Annual Reports

Title Link
Title Link
Annual Report 2024

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY26
Presentation Q3FY26

Anondita Medicare Stock Price Analysis and Quick Research Report. Is Anondita Medicare an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Anondita Medicare. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Anondita Medicare has a PE ratio of 70.9665050025918 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Anondita Medicare has ROA of 23.716% which is a good sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Anondita Medicare has a Current ratio of 3.1677.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Anondita Medicare has a ROE of 38.1445%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Anondita Medicare has a Debt to Equity ratio of 0.2944 which means that the company has low proportion of debt in its capital.

  • Sales growth: Anondita Medicare has reported revenue growth of 84.5753% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Anondita Medicare for the current financial year is 35.2054286266966%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Anondita Medicare is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Anondita Medicare is Rs 14.0827. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Anondita Medicare in Ticker for free. Also, one can get the intrinsic value of Anondita Medicare by using Valuation Calculators, which are available with a Finology ONE subscription. 

Anondita Medicare FAQs

Q1. What is Anondita Medicare share price today?
Ans: The current share price of Anondita Medicare is Rs 999.4.

Q2. What is the market capitalisation of Anondita Medicare?
Ans: Anondita Medicare has a market capitalisation of Rs 1903.33571296 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Anondita Medicare?
Ans: The PE ratio of Anondita Medicare is 70.9665050025918 and the P/B ratio of Anondita Medicare is 9.32758160467256, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Anondita Medicare share?
Ans: The 52-week high share price of Anondita Medicare is Rs 1309.58328535881, and the 52-week low share price of Anondita Medicare is Rs 435.963858142624.

Q5. Does Anondita Medicare pay dividends?
Ans: Currently, Anondita Medicare does not pay dividends. Dividend yield of Anondita Medicare is around 0%.

Q6. What are the face value and book value of Anondita Medicare shares?
Ans: The face value of Anondita Medicare shares is Rs 10, while the book value per share of Anondita Medicare is around Rs 107.1446. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Anondita Medicare?
Ans: Anondita Medicare has a total debt of Rs 33.2742063 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Anondita Medicare?
Ans: The ROE of Anondita Medicare is 38.1445% and ROCE of Anondita Medicare is 39.7548%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Anondita Medicare a good buy for the long term?
Ans: The Anondita Medicare long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Anondita Medicare undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Anondita Medicare appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Anondita Medicare’s financials?
Ans: You can review Anondita Medicare’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Anondita Medicare
X